Search Within

Roni Shouval

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (38)
  2. Journal Article (31)
  3. Research Letter (2)
  4. Correspondence (1)
Groups
  1. Epidemiology and Biostatistics (72)
  2. Hematologic Malignancies, Division of (72)
  3. Biostatistics Service (71)
  4. Center for Hematologic Malignancies (71)
  5. Department of Medicine (71)
  6. Bone Marrow Transplant (69)

More Groups

People
  1. Miguel-Angel Perales (67)
  2. Michael Scordo (62)
  3. Sean Devlin (59)
  4. Gunjan Shah (58)
  5. Maria Palomba (53)
  6. Parastoo Dahi (50)

More People

Years
  1. 2025 (8)
  2. 2024 (16)
  3. 2023 (27)
  4. 2022 (11)
  5. 2021 (2)
  6. 2020 (6)

More Years

Publications
  1. Blood (25)
  2. Bone Marrow Transplantation (8)
  3. Blood Advances (7)
  4. Transplantation and Cellular Therapy (7)
  5. Biology of Blood and Marrow Transplantation (3)
  6. British Journal of Haematology (2)

More Publications

Publishers
  1. American Society of Hematology (32)
  2. Elsevier Inc. (13)
  3. Nature Publishing Group (12)
  4. American Association for Cancer Research (3)
  5. Cell Press (2)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (72)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of the impact of tocilizumab use in recipients of CAR T cells for non-Hodgkin lymphoma
    Meeting Abstract

    Cassanello, G.; Luttwak, E.; Devlin, S. M.; Luna De Abia, A.; Corona, M.; Landego, I.; Parascondola, A.; Saldia, A.; Tomas, A. A.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • CNS radiotherapy as bridging prior to CAR T-cell therapy for non-Hodgkin B-cell lymphoma
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S. M.; Hubbeling, H.; Tringale, K.; Shah, G. L.; Tomas, A. A.; Shouval, R.; Hajj, C.; Fregonese, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Higher CD4+T cell counts after CAR-T in large B-cell lymphomas are significantly associated with better overall survival
    Meeting Abstract

    Luan, D.; Shouval, R.; Fei, T.; Luttwak, E.; Luna, A.; Corona, M.; Palomba, M. L.; Parascondola, A.; Scordo, M.; Shah, G. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-world outcomes in patients with transformed follicular lymphoma treated with CD19-targeting CAR-T therapy
    Meeting Abstract

    Rivas-Delgado, A.; Luttwak, E.; Drill, E.; Goldstein, I.; Landego, I.; Tomas, A. A.; Parascondola, A.; Saldia, A.; Caron, P.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • An inflammatory biomarker signature reproducibly predicts CAR-T treatment failure in patients with aggressive lymphoma across the ZUMA trials cohorts
    Meeting Abstract

    Raj, S.; Xie, J.; Fei, T.; Song, Q.; Kim, J. J.; To, C.; van den Brink, M. R. M.; Perales, M. A.; Mattie, M.; Shouval, R.
    Blood (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J. R.; Devlin, S. M.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Wills, B.; Tomas, A. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT imaging biomarkers for car-T cell therapy outcomes in large-B-cell lymphoma
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M.; Luttwak, E.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The simplified comorbidity index stratifies non-relapse mortality in patients receiving allogeneic hematopoietic stem cell transplant after reduced-intensity conditioning: A CIBMTR validation study
    Meeting Abstract

    Shouval, R.; Brown, S.; Devlin, S. M.; Elias, S.; Allbee-Johnson, M.; Pasquini, M.; Chhabra, S.; Perales, M. A.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save